Source - RNS
RNS Number : 6098K
Byotrol PLC
22 September 2016


22 September 2016


Byotrol plc


("Byotrol" or the "Company")


Result of AGM


Byotrol plc, the developer of anti-microbial technologies, confirms that at its Annual General Meeting held earlier today, all resolutions were duly passed.

A copy of the presentation used at the AGM is available on the Company's website


Byotrol plc

01925 742 000

David Traynor - Chief Executive


finnCap Ltd

020 7220 0500

(Nominated Adviser & Broker)

Geoff Nash/Carl Holmes/James Thompson - Corporate Finance

Mia Gardner - Corporate Broking


Notes to Editors:


Byotrol plc (BYOT.L), quoted on AIM, is a specialist developer of residual antimicrobial technologies, identifying, developing, formulating and commercialising cutting-edge antimicrobial technologies.

Our patented suite of technologies deliver powerful broad-spectrum efficacy with residual performance optimised against commonly occurring and industry-specific pathogens


Founded in 2005, the Company has developed the technology that creates easier, safer and cleaner lives.


For more information, please go to



This information is provided by RNS
The company news service from the London Stock Exchange